← Back to Clinical Trials
Recruiting NCT05702749

Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas

◆ AI Clinical Summary

This study tests whether balance and physical therapy exercises done before treatment for vestibular schwannomas (non-cancerous tumors on the balance nerve) can help patients recover better. Researchers will compare patients who do pre-treatment rehabilitation exercises to those who don't receive this therapy before surgery or radiation treatment.

Key Objective: The trial evaluates whether pre-treatment physical therapy can improve balance and recovery outcomes in patients scheduled for vestibular schwannoma surgery or radiosurgery.

Who to Consider: Patients diagnosed with vestibular schwannomas who are planning to undergo surgery or radiosurgery should consider enrolling if they are interested in potentially improving their balance and recovery through pre-treatment rehabilitation.

Trial Parameters

Condition Vestibular Schwannoma
Sponsor Medical College of Wisconsin
Study Type INTERVENTIONAL
Phase N/A
Enrollment 36
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-01-22
Completion 2027-07
Interventions
Microsurgical resection of VSStereotactic radiosurgeryPREHAB

Brief Summary

The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patients undergoing pretreatment rehab (PREHAB) or no PREHAB when managed with either surgery or radiosurgery.

Eligibility Criteria

Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Male or female participants ≥18 years of age. 3. Initial diagnosis of a Vestibular Schwannoma confirmed by a physician with an internal auditory canal (IAC) MRI, in accordance with standard or institutional practice 4. VS patients who present with a tumor size ≤2.5 cm and will be treated with surgery or SRS 5. Eastern Cooperative Oncology Group (ECOG) Performance Status \<2 6. Within 14 days of study registration, participants must have normal laboratory values that support safe treatment, at the discretion of the treating investigator 7. Be willing to adhere to outlined study protocol criteria and complete self-reported questionnaires (translations may be made available if the patient' primary language is not English). 8. For females of reproductive potential: must have a negative urine or serum pregnancy test 7 prior to enrollment and agreement to use of highly effective contraception method during study pa

Related Trials